Skip to Content

Nanjing Pharmaceutical Co Ltd Class A 600713

Morningstar Rating
CNY 4.74 +0.02 (0.42%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

600713 is trading at a 31% discount.
Price
CNY 4.73
Fair Value
CNY 4.45
Uncertainty
Very High
1-Star Price
CNY 5.78
5-Star Price
CNY 7.96
Economic Moat
Myxx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 600713 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 4.72
Day Range
CNY 4.694.75
52-Week Range
CNY 3.856.45
Bid/Ask
CNY 4.73 / CNY 4.74
Market Cap
CNY 6.21 Bil
Volume/Avg
9.6 Mil / 9.5 Mil

Key Statistics

Price/Earnings (Normalized)
10.42
Price/Sales
0.11
Dividend Yield (Trailing)
2.97%
Dividend Yield (Forward)
2.97%
Total Yield
2.95%

Company Profile

Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Value
Total Number of Employees
4,903

Comparables

Valuation

Metric
600713
002424
600285
Price/Earnings (Normalized)
10.4252.2826.59
Price/Book Value
0.972.234.87
Price/Sales
0.112.044.07
Price/Cash Flow
4.4726.0315.20
Price/Earnings
600713
002424
600285

Financial Strength

Metric
600713
002424
600285
Quick Ratio
1.011.02
Current Ratio
1.461.33
Interest Coverage
2.75
Quick Ratio
600713
002424
600285

Profitability

Metric
600713
002424
600285
Return on Assets (Normalized)
1.81%2.26%13.37%
Return on Equity (Normalized)
9.27%3.94%22.70%
Return on Invested Capital (Normalized)
5.84%4.46%20.78%
Return on Assets
600713
002424
600285
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoHmrdkhmwMdc$697.4 Bil
JNJ
Johnson & JohnsonJbhsgnsSjlx$353.8 Bil
MRK
Merck & Co IncFxvcxdkmBpppk$332.3 Bil
ABBV
AbbVie IncVhhbwnhhScd$282.6 Bil
AZN
AstraZeneca PLC ADRYslfzqxfqWslx$232.3 Bil
NVS
Novartis AG ADRSjbgprjltDmd$200.1 Bil
RHHBY
Roche Holding AG ADRWgvcmctjvxBmgv$195.3 Bil
AMGN
Amgen IncFqmdydwzsWzy$144.5 Bil
PFE
Pfizer IncYnjhxjdcNky$143.8 Bil
SNY
Sanofi SA ADRHhcsbrkSqy$122.2 Bil

Sponsor Center